Karah Herdman Parschauer
Independent DirectorMs. Karah Herdman Parschauer, J.D. served as an Independent Director of Anebulo Pharmaceuticals, Inc. since February 2021 until November 20, 2023. She serves as an Independent Director of Tenaya Therapeutics, Inc. since December 22, 2021. She is Director of Alliance for Regenerative Medicine. Ms. Parschauer served as a Director of Arcturus Therapeutics Holdings Inc. (formerly known as Arcturus Therapeutics Ltd.) since June 18, 2019 until August 25, 2021. Ms. Parschauer has been Vice President and Secretary of Dimension Therapeutics, Inc. since November 7, 2017. Ms. Parschauer had been Executive Vice President of Ultragenyx Pharmaceutical Inc. since June 20, 2016 and serves as its Executive Vice President of Corporate Affairs. She serves as Chief Legal Officer for Ultragenyx Pharmaceutical Inc. since December 2021. She was General Counsel for Ultragenyx Pharmaceutical Inc. since June 20, 2016. Prior to Ultragenyx, Ms. Parschauer served in various executive capacities and most recently as Vice President, Associate General Counsel, at Allergan plc, a pharmaceutical company, from June 2005 until June 2016. Ms. Parschauer served as Head of Legal and Compliance for Allergan’s Medical Aesthetic division and Chief Privacy Officer. Prior to Allergan, Ms. Parschauer was an Associate Attorney/Attorney at Latham & Watkins LLP where she practiced in the areas of mergers and acquisitions, securities offerings and corporate governance. She has been Independent Director of Evolus, Inc since July 15, 2019. She has been a Director of Dimension Therapeutics, Inc. since November 7, 2017. She is a Member of the State Bars of California and Illinois. Ms. Parschauer received a B.A. in Biology from Miami University and a Juris Doctor from Harvard Law School.
Positions
- Company NameEvolus, Inc.Stock CodeEOLSPositionIndependent DirectorColleagues
- DMDavid MoatazediPresident, CEO & Director
- VMVikram MalikIndependent Chairman of the Board
- TMTatjana MitchellChief Financial Officer
- RARui AvelarChief Medical Officer and Head of Research & Development
- NSNareg SagherianHead of Global Investor Relations & Corporate Communications
- KKKurt KnabSenior Vice President of Sales
- DNDavid N. GillIndependent Director
- AGAlbert G. WhiteIndependent Director
- Company NameUltragenyx Pharmaceutical Inc.Stock CodeRAREPositionChief Legal Officer & Executive VP of Corporate AffairsColleagues
- EDEmil D. KakkisFounder, President, CEO & Director
- DGDaniel G. WelchIndependent Non-Executive Chairman
- HHHoward HornExecutive VP of Corporate Strategy & CFO
- KHKarah Herdman ParschauerChief Legal Officer & Executive VP of Corporate Affairs
- EHErik HarrisExecutive VP & Chief Commercial Officer
- ECEric CrombezChief Medical Officer & Executive VP
- MKMatthew K. FustIndependent Director
- MAMichael A. NarachiIndependent Director
- SSShehnaaz SulimanIndependent Director
